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ABSTRACT
Purpose/Background: Pain can adversely affect muscle functioning by inhibiting muscle contractions.
Delayed onset muscle soreness was used as a tool to ascertain whether a topical menthol-based analgesic
or ice was more effective at reducing pain and permitting greater muscular voluntary and evoked force.
Methods: Sixteen subjects were randomized to receive either a topical gel containing 3.5% menthol or topical application of ice to the non-dominant elbow flexors two days following the performance of an exercise
designed to induce muscle soreness. Two days later, DOMS discomfort was treated with a menthol based
analgesic or ice. Maximum voluntary contractions and evoked tetanic contractions of the non-dominant
elbow flexors were measured at baseline prior to inducing muscle soreness (T1), two days following inducing DOMS after 20 (T2), 25 (T3) and 35 (T4) minutes of either menthol gel or ice therapy. Pain perception
using a 10-point visual analog scale was also measured at these four data collection points. Treatment analysis included a 2 way repeated measures ANOVA (2 × 4).
Results: Delayed onset muscle soreness decreased (p = 0.04) voluntary force 17.1% at T2 with no treatment effect. Tetanic force was 116.9% higher (p<0.05) with the topical analgesic than ice. Pain perception
at T2 was significantly (p=0.02) less with the topical analgesic versus ice.
Conclusions: Compared to ice, the topical menthol-based analgesic decreased perceived discomfort to a
greater extent and permitted greater tetanic forces to be produced.
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INTRODUCTION
Delayed onset muscle soreness (DOMS) is a common consequence of unaccustomed exercise or
overtraining especially with the inclusion of extensive eccentric contractions.1 DOMS is commonly
observed with athletes, weight lifters, and is frequently observed among recreational athletes.1 The
presence of DOMS inhibits muscle activity or motor
performance for up to several days following the initiating event.2 One of the major symptoms of DOMS
is pain1 which can cause inhibition of force production of the involved muscle.1,3
Various methods of ice application including cold
water immersion have been used to treat DOMS with
inconclusive results.4 Isabell et al5 found no clinically significant effect of ice massage on DOMS.
Connolly et al4 countered in their review that cold
water immersion has been shown to be effective in
providing some relief of DOMS. Although ice is commonly used to alleviate pain6 the evidence for its
effectiveness for relieving DOMS is contradictory.
Topically applied gels, which contain menthol, are
also used as analgesics.7-9 Topically applied menthol
gels result in a cooling sensation and are reported to
act as a counterirritant to reduce the sensation of
pain.9 Menthol generates feelings of cold via the transient receptor potential family of ion channels or
(TRP’s). TRP’s are found throughout the body, but
TRPM8 are found mainly within thermosensitive neurons, which in addition to responding to reductions in
temperature are also particularly sensitive to menthol.10-15 TRPM8 serves as a neuronal sensor of cold
temperatures and is essential for receiving input
regarding innocuous cool and noxious cold sensations.16,17 Utilization of calcium imaging techniques
has demonstrated that upon the application of menthol to cloned TRPM8 cells, a heavy intracellular influx
of calcium ions caused neural depolarization due to
the opening of non-selective calcium permeable cation channels.10-15 This increase in sensitization of the
thermosensitive neurons is what leads to the perceptions of coolness with topical menthol application.
Stimulation of these thermosensitive neurons is also
associated with an analgesic effect. Afferent thermosensitive neurons which are stimulated by moderate
cooling or the application of menthol have been found
to have an inhibitory effect on the nociceptive afferent

neurons and on the dorsal-horn neurons which conduct
pain impulses to the thalamus.18 This analgesic effect of
menthol was demonstrated in vitro by Haeseler et al19
when studying the effect of an electrical stimulus
applied to human skeletal muscle tissue after the tissue
was exposed to menthol. At various menthol application strengths, inactivated sodium channels were measured to determine the effect on depolarization. It was
demonstrated that the menthol blocked the alpha subunit of voltage gated sodium channels, therefore causing hyperpolarization of the nervous membrane and a
block in the signal of pain transduction. This study demonstrated that the application of menthol could have an
analgesic effect through exerting an inhibitory gate control over nociceptive inputs. There are no studies, to
date, which have compared the analgesic effects of topical applications of ice with menthol-based gel on DOMS
symptoms.
Therefore, the purpose of this study was to compare
applications of topical menthol with ice on pain, maximum voluntary contraction and evoked tetanic force
during DOMS. It was hypothesized that the menthol
based topical analgesic would be more effective than
ice in alleviating DOMS-related symptoms (pain and
force reductions). Thus menthol’s analgesic effect on
pain would improve strength output.
METHODS
Participants
Sixteen (Menthol [Biofreeze®] group: 24.2 + 2.1 yrs,
181.6 + 4.5 cm, 76.1 + 10.3 kg; Ice group: 22.8 + 1.8
yrs, 178.3 + 3.9 cm, 73.9 + 7.5 kg) healthy, physically
active subjects (performed regular physical activity a
minimum of tice per week) including 12 males and
4 females from Memorial University of Newfoundland
were randomized to receive either a topical gel containing 3.5% menthol or a topical application of ice
(using an ice bag) to their non-dominant elbow flexors
two days following performing an exercise designed to
induce DOMS in this muscle group. No participant had
any previous history of cardiopulmonary, neurological, cognitive problems, sensory deficits, cold intolerance, or hypersensitivity. The upper limbs were visually
checked to ensure the absence of any skin wounds,
lesions and rashes. All subjects were given verbal information on the procedure of study as well as a brief
overview of the purpose of the research. A Physical

The International Journal of Sports Physical Therapy | Volume 7, Number 3 | June 2012 | Page 315

Activity Readiness Questionnaire (PAR-Q)20 was given
to every subject to ensure the subjects’ health status
was sufficient to participate in physical activity.
Using a random allocation method, subjects were
divided into two groups; menthol based topical analgesic and ice intervention groups. All subjects read
and signed a written informed consent document
before participation that was approved by The Human
Investigation Committee of Memorial University of
Newfoundland.
Delayed Onset Muscle Soreness (DOMS)
Exercise Intervention
Following completion of the informed consent process, the PAR-Q and being assigned to an experimental group all subjects were instructed to sit with their
upper arm supported on an inclined padded bench
and hold a free weight dumbbell to provide the resistance in their non-dominant hand. The lower arm
and dumbbell hung freely over the edge of the bench.
The one repetition maximum (1 RM) was determined
for the elbow flexors of non-dominant arm (the left
arm for all subjects in this experiment)21 using the
procedure described by Robbins et al.22,23 According
to this procedure an additional 10% was added to the
1 RM resistance, in order to successfully induce
DOMS. Initially, the investigators helped raise the
resistance to full elbow flexion with minimal assistance from the subject. The subject then performed
an eccentric contraction to return the weight to starting position2 over a 5s duration. Each subject performed ten sets of 10 repetitions of this eccentric
exercise of the non-dominant arm. If a subject was
not able to control the lowering of the weight over
the 5s duration the resistance was reduced by 2.5 kg
to ensure the completion of 10 sets. A one-minute
recovery period was provided between each set.
DOMS was induced in this study as an experimental
tool to induce musculotendinous pain.
Menthol Based Topical Analgesic and Ice
Treatment Interventions
The treatment interventions were applied approximately 48 hours or two days following the DOMS
inducing session. For the menthol gel group, 2ml of
Biofreeze®, a gel containing 3.5% menthol was applied
topically over the belly of the biceps brachii. The mode
of application did not involve substantial force,

pressure or rubbing and thus any reflex activation
would not have been expected. This dose of Biofreeze®,
was based upon the estimate that the average skin surface area over the biceps brachii was approximately
400 cm² and the recommended dosage of Biofreeze®
of 1 ml per 200 cm².24 Twenty minutes (T2) following
the application of the menthol gel each participant
completed an assessment of their MVC, evoked tetanic
force and perceptions of pain. These assessments
were repeated at 25 (T3) and 35 (T4) minutes following the application of the menthol gel. Whereas the
effect of menthol-induced reduced vascular conductance has been reported to endure for at least 20
min,24,25 the subjective cooling effect has been reported
to last up to 70 min in some subjects (mean 32 min).9
The protocol for application of the ice was similar to
that of the menthol gel. Subjects who were randomized into this group underwent the same baseline
assessment of their MVC evoked tetanic force and
their perceptions of pain (T1) prior to inducement
of DOMS. Then these individuals reported to the
laboratory approximately 48 hours (or 2 days) following the DOMs inducement protocol. At this time
.5kg of crushed ice in a plastic bag was placed over
the non-dominant biceps brachii for 20 minutes and
then removed.26,27 Assessments of MVC, evoked tetanic
force and their perceptions of pain were repeated
immediately following the removal of the ice (T2),
and at 25 (T3) and 35 (T4) minutes following initial
application of the ice.
One researcher performed all the intervention applications, while another researcher was blinded to the
group allocation during testing. Anonymous codes
were assigned for analysis so that only the third
researcher who did not perform the data analysis
was cognizant of group allocation.
Dependent Variables
Measurements of voluntary (elbow flexor isometric
MVC) and evoked (tetanic force) contractile properties
were randomly allocated. While subjects sat upright in
a chair, the left shoulder and elbow were flexed at 90°
with the forearm vertical and fully supinated. The
upper arm was fastened to the chair via an adjustable
strap to avoid movement during voluntary force
measurements. Both forearm and wrist of the testing
arm were rested on a padded support and secured to a
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strap attached to a high tension wire to a Wheatstone
bridge configuration strain gauge (Omega Engineering
Inc., LCCA 250, Don Mills, Ontario, Canada), amplified
(Biopac Systems Inc., Holliston, Massachusetts; DA
100 and analog to digital converter MP100WSW) and
monitored on computer (Dell Inspiron 6000, St. John’s,
Newfoundland, Canada). All data were stored on a
computer at a sampling rate of 2000 Hz. Data were
recorded and analyzed with a commercially designed
software program (AcqKnowledge III, Biopac Systems
Inc., Holliston, Massachusetts).
To assess peripheral (muscle) force changes associated with DOMS and the treatment interventions,
bipolar surface stimulating electrodes were secured
to the proximal anterior portion of the forearm flexors
and deltoid-biceps brachii intersection. Similar to
previous research from this laboratory30 stimulating
electrodes, 4–5 cm in width were constructed in the
laboratory from aluminum foil, paper coated with
conduction gel (Signa Creme, Parker Laboratories,
Fairfield, New Jersey) and immersed in water. The
electrodes length was sufficient to wrap the width
of the muscle belly. The electrodes were placed in
approximately the same position for each subject.
Tetanic stimulation was evoked with electrodes connected to a high-voltage stimulator (Digitimer Stimulator Model DS7H+ Hertfordshire, UK). A stimulation
frequency of 50 Hz was maintained for a duration of
3 s with a pulse duration set at 50 μs. Stimulation was
started with voltage at 100 V and amperage at 200 mA
and progressively increased by 200 mA until 1 ampere
was reached. If the subject could tolerate greater force
then voltage was increased incrementally by 50 V.
The purpose of the tetanic stimulation was to determine the maximum evoked force output that could
be tolerated (pain perception) by the individuals.
Maximum Voluntary Contraction (MVC) Force
All subjects performed 2–3 MVCs trials. Verbal instructions were given to each subject to maximally contract the elbow flexors as hard and fast as possible.
During the contraction, verbal motivation and visual
feedback was provided by the investigator to promote
a maximal response. The isometric contraction lasted
for 4-5 s. Subjects were given a rest period of at least 2
min between each MVC. Peak force was measured as
the greatest difference between the pre-MVC or resting value (approximately 1s prior to contraction) and

the greatest force amplitude. If there was a >5% difference between the first 2 MVC trials, the subject
was asked to perform a third trial, and the highest
MVC force was recorded.
Visual Analogue Scale
A soreness rating scale was used with a visual analogue scale (VAS) to collect the soreness perception
levels prior to testing.2,28 Since the subject’s were
maximally exerting and physically restricted during
the MVCs and with the treatment applications, subjects were instructed to verbally report the perception of soreness levels to the researchers who would
record the response on the 10-point, 100 mm VAS
scale. VAS has been reported to be a valid indicator
of pain with excellent consistency.29
Statistical Analysis
Treatment analysis included a 2 way repeated measures ANOVA (2 × 4)(GB-STAT for MS Windows, version 7.0, Dynamic Microsystems Inc., Silver Spring,
MD) with factors including treatment intervention
(menthol based topical analgesic and ice) and time
(T1-T4). The effect of DOMS on voluntary and evoked
forces was analyzed with repeated measures ANOVA.
Differences were considered significant when p values were below an alpha level of 0.05. A post hoc
Bonferroni- Dunn’s procedure was used to detect
specific significant differences. Effect sizes (ES =
mean change / standard deviation of the sample
scores) and confidence intervals were also calculated
and reported.31 Cohen applied qualitative descriptors
for the effect sizes with ratios of <0.41, 0.41-0.7, and
>0.7 indicating small, moderate and large changes
respectively. Data were reported as mean + SD.
RESULTS
A post-hoc analysis of the statistical power (for a
two-sided test) calculated for an alpha of 0.05 ranged
from 0.2 for MVC force measures (insignificant findings) to 0.84, 0.97 and 0.98 for tetanic force, VAS
scores at rest and VAS scores during the MVC respectively. There were no significant differences between
groups for any baseline (T1) measures.
Voluntary Muscle Force and Activation
There was no significant main effect or interactions
for the treatment interventions. There was a significant
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Figure 1: Figure illustrates a main effect for time associated
with changes in maximum voluntary contraction (MVC) force
of the non-dominant elbow ﬂexors. The asterisk indicates a
signiﬁcant (p=0.04) difference between T1 (pre-test) and T2
(2 days following DOMS and 20 min following intervention
application) MVC force. Columns and bars represent means ±
standard deviation (SD).

(p = 0.04; ES=0.54) main effect for time, with a
DOMS-induced decrease in MVC force of 17.1% from
T1 to T2 (Figure 1). There were no significant MVC
force differences between T2, T3 and T4 (Table 1).
Evoked Muscle Force
There was a tendency with a large effect size (p =
0.06; ES=1.2) for tetanic force to decrease over time
with 43.4%, 35.1%, and 31.2% decreases of T2, T3 and
T4 respectively, compared to T1 (Figure 2). Tetanic
force changes illustrated a significant main effect for

Figure 2: Figure illustrates a tendency (p=0.06) with a large
effect size (ES=1.2) for a main effect for time (data collapsed
over treatments) associated with evoked tetanic force of the
non-dominant (DOMS-induced) elbow ﬂexors. Columns and
bars represent means ± standard deviation (SD).

the treatments (p<0.05; ES=1.1) with the menthol
based topical analgesic allowing 116.9% greater tetanic
force (89.4 N ± 60.7) output than the ice treatment
(41.2 ± 43.6). Although not statistically significantly
different (p=0.17), tetanic forces following the ice
treatment at T2, T3 and T4 were 56.5%, 78.7% and
66.1% lower than tetanic forces following the respective times with the Biofreeze treatment (Table 1).
Pain Scales
There was no significant difference in pain perception pre-treatment. Although there was no significant

Table 1. Treatment by time interactions. The ﬁrst series of numbers represents mean ± standard
deviations whereas the subsequent numbers below represent the 95% conﬁdence interval (CI).
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group by time interaction, soreness perception associated with the MVC showed trends with large effect
size for both treatment and time. The soreness associated with a MVC following ice application (3.9 ± 0.5)
tended to be 33% greater (p=0.08; ES=1.8) than following the topical analgesic application (3.0 ± 0.4).
Soreness associated with a MVC had a tendency with
a small effect size (p=0.1; ES=0.12) to decline over
time with 13.1% and 17.7% less soreness respectively,
perceived at T3 (3.3 ± 0.98) and T4 (3.1 ± 1.2) compared to T1 (3.8 ± 1.02). There was a significant
(p=0.025; ES=1.2) difference in soreness perception
with the VAS scale between the application of ice and
the menthol based topical analgesic. Soreness perception was 63.1% less with application of the topical
analgesic (1.1 ± 0.4) compared to the ice (3.1 ± 1.7).
DISCUSSION
The most important results of this study suggest that
a menthol based topical analgesic was more effective than ice for relieving soreness associated with
DOMS while at rest or during muscle contractions.
The topical analgesic also permitted greater evoked
tetanic forces to be produced as compared to ice.
Menthol and ice are widely used as topical analgesics. Ice is reported to be effective in reducing pain
with soft tissue injuries32,33 and has also been widely
used in relieving the symptoms of DOMS.4,34 It is suggested that the cold temperature significantly reduces
the pain perceived due to DOMS.34 However, other
studies report that ice massage5,35 have minimal
effects on reducing DOMS symptoms. Although ice
is commonly used to alleviate pain,6 there is conflicting evidence regarding its effectiveness for relieving
DOMS. In the present study ice was less effective
than a menthol based topical analgesic for relieving
DOMS symptoms. The menthol based topical analgesic showed both large magnitudes of change over the
testing periods as well as achieving minimal clinical
importance. A number of studies36-38 have indicated
that a change of 10-13 mm on a VAS scale of 100 mm
represents the minimal clinically significant difference. The present study anchored numbers from 010 with a distance of 10 mm between each numeral.
The VAS score with the menthol based topical analgesic of 1.1 was substantially lower than the score
associated with the ice treatment (3.1) illustrating a
clinically significant difference in pain perception.

Menthol has been reported to be effective in relieving pain with mild to moderate muscle strains.39 Topical application of a menthol gel along with the
chiropractic adjustment showed significant reduction in low back pain.40 Yosipovitch et al.9 reported
that while menthol has a high skin irritating effect it
did not differ from alcohol in reducing itch and pain
sensations. However, Galeotti et al.7 indicated that
menthol’s analgesic properties are mediated through
a selective activation of opioid receptors. The feeling
of coolness experienced when applying menthol is
achieved by sensitization of the thermosensitive
neurons that also possess analgesic properties.7 Using
mice, Galeotti et al.7 reported an increase in heat
pain threshold. Furthermore, menthol has been
shown to activate temperature-activated transient
receptor potential (TRP) ion channels such as
TRPM8,41 TRPV3 and inhibits TRPA1 providing a
rationale for its use as an analgesic.8 Stimulation of
these thermosensitive neurons is also associated
with an analgesic effect. Afferent thermosensitive
neurons are stimulated by the application of menthol, have an inhibitory effect on the nociceptive
afferent neurons and dorsal-horn neurons, which
conduct pain impulses to the thalamus.18
Another possible mechanism for the analgesic effect
of menthol may be related to the inflammation or
swelling associated with DOMS.4 Olive et al.24 reported
a significant reduction in vascular conductance
within 60s of menthol application, which was maintained for at least 10 minutes. Similarly animal studies have shown a reduced pressor response to exercise
(decreased blood pressure) reducing blood flow to
the application area.42,43 Unfortunately the extent of
swelling was not measured in the present study and
thus the effect of the menthol gel on DOMS-induced
inflammation cannot be verified or quantified in this
study. Hence, the mechanisms underlying the lower
soreness scores on the VAS cannot be specified in the
present study but may be attributed to one or a combination of inflammation reduction, counterirritant
activation and inhibition of specific thermosensitive
ion channels, or opioid receptors.
The menthol based topical analgesic permitted greater
evoked tetanic forces following DOMS than ice. Unfortunately, VAS for pain was not employed during the
tetanic contractions. However, all participants in this
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study and the many previous studies from this laboratory have all commented on the substantially greater
discomfort experienced during evoked tetanic versus
voluntary contractions. Electrical stimulation of muscle through the skin can activate cutaneous pain
receptors,44 with greater magnitudes of pain experienced with increasing frequency of stimulation.45
Furthermore the stimulator provides synchronous
muscle activation45 rather than a typical physiological
asynchronous stimulation46 resulting in a cramp-like
sensation. This cramp-like contraction can also stimulate mechanical nociceptors contributing to the pain
sensation.44 Hence in the present study, the milder
discomfort associated with a voluntary contraction
did not allow subjects to differentiate between the
topical analgesic and ice but the greater discomfort or
pain of the tetanic cramp-like contraction was ameliorated to a greater degree by the menthol based topical
analgesic. Thus the menthol based topical analgesic
provided greater pain tolerance allowing higher evoked
contraction forces to be produced. In terms of injury
rehabilitation, the menthol-based analgesic would allow
higher contraction forces to be elicited with functional
electrical stimulation training.
The greatest limitation of the present study is related
to the individual responses to pain. Behm and StPierre47 reported a correlation 0.1 between pain and
muscle activation. The high variability with some of
the data in the present study also reflects the very different responses of each individual to pain. Thus, predictably there was no significant correlation between
pain and changes in force. A further limitation could
have been that the treatments could have distinctive
time courses. The present study utilized early and
delayed testing times for the treatments in order to
identify if one treatment was more likely to have a
greater effect soon after or later after application.
CONCLUSIONS
The results of the present study indicate that a menthol
based topical analgesic was more effective than ice for
decreasing DOMS-induced symptoms of pain and
increasing evoked tetanic force. Hence, a menthol
based analgesic would be recommended for reducing
DOMS-induced symptoms for at least 35 minutes after
the application. While patients with injuries were not
employed in this study, the greater tetanic force with
the menthol analgesic might suggest that more intense

or aggressive muscle stimulation therapy during rehabilitation might be possible with such a therapeutic
agent. Finally DOMS was used as a model to induce
pain in the present study. The results may also apply to
other musculoskeletal pain afflictions; however further
research should investigate injured populations (e.g.
strains, sprains). Furthermore, previous research24 indicates that the effects of menthol-based gels may work
within a minute of application making them more time
efficient than ice.
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